Healthcare Services

Deep Brain Stimulation in Parkinson’s Disease Market Trends and Opportunities 2026–2030

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Deep Brain Stimulation In Parkinson`s Disease Market In 2026 And What Value Is Projected For 2030?

The market size for deep brain stimulation in Parkinson’s disease has demonstrated robust growth in recent years. It is projected to expand from $3.27 billion in 2025 to $3.49 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.7%. This historical growth can be ascribed to factors such as the increasing prevalence of Parkinson’s disease, the growing adoption of DBS devices, heightened awareness of advanced neuromodulation therapies, the expansion of neurosurgical infrastructure, and rising healthcare spending.

The deep brain stimulation in parkinson’s disease market size is anticipated to experience robust expansion over the coming years. This market is projected to grow to $4.49 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.4%. The expansion observed during the forecast period can be primarily attributed to the increasing demand for personalized neuromodulation therapies, enhanced investments in research and clinical trials, improved access to tele-neurology services, broader reimbursement coverage, and the rising adoption of MRI-compatible and rechargeable devices. Significant trends for the forecast period include technological progress in closed-loop and directional stimulation, innovations concerning rechargeable and long-life IPGs, developments in AI-assisted DBS programming, ongoing research and development into minimally invasive surgical techniques, and advancements in remote monitoring and telemedicine capabilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30568&type=smp

Which Major Factors Are Driving The Expansion Of The Deep Brain Stimulation In Parkinson`s Disease Market?

The increasing prevalence of Parkinson’s disease patients is projected to fuel expansion within the deep brain stimulation in Parkinson’s disease market. This progressive neurological condition, characterized by tremors, rigidity, slow movement, and poor balance due to declining dopamine neurons, sees its patient numbers rise primarily due to an aging demographic, as the risk escalates with age. Deep brain stimulation offers a management strategy for Parkinson’s disease by applying focused electrical impulses to specific brain areas, thereby alleviating motor symptoms, enhancing life quality, and lessening reliance on prolonged medication. For example, the Parkinson’s Foundation, a US-based non-profit organization, reported that approximately 1.1 million individuals in the United States are living with Parkinson’s disease in 2025, a figure anticipated to reach 1.2 million by 2030, with roughly 90,000 new cases identified annually and over 10 million people impacted worldwide. Consequently, the growing count of Parkinson’s disease sufferers is a key impetus for the deep brain stimulation in Parkinson’s disease market’s development. Increased healthcare spending is anticipated to boost the growth of the deep brain stimulation in Parkinson’s disease market in the future. Healthcare expenditure encompasses all financial allocations by governments, businesses, and individuals towards health services, such as medical interventions, hospital stays, pharmaceuticals, and public health programs. The escalating need for healthcare funds stems from the growing incidence of chronic conditions that demand expensive and prolonged treatment. Enhanced healthcare spending facilitates deep brain stimulation in Parkinson’s disease by financing complex surgical operations, necessary equipment, and ongoing patient care. This improves patient results through greater availability of this successful therapy, which reduces motor symptoms and elevates quality of life. As an illustration, the Office for National Statistics, a UK-based government body, reported in May 2024 that overall healthcare expenditure rose by 5.6% in nominal terms during 2023, representing a 0.9% increase over 2022. Thus, the upward trend in healthcare expenditure is a significant factor driving the expansion of the deep brain stimulation in Parkinson’s disease market.

What Are The Key Segments Of The Deep Brain Stimulation In Parkinson`s Disease Market?

The deep brain stimulation in parkinson`s disease market covered in this report is segmented –

1) By Product Type: Implantable Pulse Generators (IPGs), Electrodes And Leads, External Programmers, Accessories And Consumables

2) By Technology: Conventional Deep Brain Stimulation (DBS) Systems, Closed Loop Deep Brain Stimulation (DBS) Systems, Wireless Deep Brain Stimulation (DBS) Systems

3) By Service Type: Pre-Surgical Evaluation Services, Surgical Implantation Services, Device Programming Services, Patient Monitoring Services, Maintenance And Follow-Up Services, Rehabilitation Support Services, Tele-Neurology Support Services, Training And Education Services

4) By Application: Tremor Management, Rigidity And Stiffness Management, Bradykinesia (Slow Movement) Management, Dyskinesia Management

5) By End-Users: Hospitals, Ambulatory Surgical Centres, Neurology Clinics

Subsegments:

1) By Implantable Pulse Generators (IPGs): Rechargeable Implantable Pulse Generators, Non-Rechargeable Implantable Pulse Generators, Directional Implantable Pulse Generators

2) By Electrodes And Leads: Cylindrical Electrodes, Directional Electrodes, Stimulation Leads

3) By External Programmers: Handheld External Programmers, Desktop External Programmers, Wireless External Programmers

4) By Accessories And Consumables: Extension Cables, Battery Chargers, Surgical Tool Kits

What Key Trends Are Influencing The Development Of The Deep Brain Stimulation In Parkinson`s Disease Market?

Major companies within the deep brain stimulation in Parkinson’s disease market are prioritizing the creation of advanced products, including miniaturized rechargeable implantable pulse generators and integrated remote programming platforms, aiming to improve patient comfort and care accessibility. Miniaturizing rechargeable implantable pulse generators involves creating these battery-powered neurostimulation devices with significantly reduced dimensions, allowing for less invasive surgical placement while maintaining consistent delivery of reliable therapeutic electrical pulses over long periods. As an example, in January 2024, Abbott Laboratories, a US-based multinational medical devices and healthcare company, introduced its Liberta RC DBS system. This system represents a miniaturized rechargeable deep brain stimulation platform featuring remote programming capabilities, specifically intended for individuals with movement disorders like Parkinson’s disease and essential tremor. Furthermore, the solution offers the longest recharging duration among FDA-approved DBS systems, with a minimal requirement of just 10 annual recharge sessions for most users, and incorporates the NeuroSphere Virtual Clinic, allowing patients to interact with their doctors and receive treatment adjustments from the convenience of their homes.

Which Major Firms Influence Developments In The Deep Brain Stimulation In Parkinson`s Disease Market?

Major companies operating in the deep brain stimulation in parkinson`s disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.

Read the full deep brain stimulation in parkinson`s disease market report here:

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-in-parkinsons-disease-market-report

Which Region Is Anticipated To See The Fastest Growth In The Deep Brain Stimulation In Parkinson`s Disease Market?

North America was the largest region in the deep brain stimulation in parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation in parkinson`s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Deep Brain Stimulation In Parkinson`s Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30568&type=smp

Browse Through More Reports Similar to the Global Deep Brain Stimulation In Parkinson`s Disease Market 2026, By The Business Research Company

Deep Brain Stimulation Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report

Deep Brain Stimulation Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-device-global-market-report

spinal cord stimulation global market report

https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795